MONCTON, NB,
June 24, 2021 /CNW/ -
Organigram Holdings Inc. ("Organigram" or the
"Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that
it has a filed a preliminary short form base shelf prospectus (the
"Base Shelf Prospectus") with the securities commissions in
each of the provinces and territories of Canada. A corresponding shelf registration
statement on Form F-10 (the "Registration Statement") has
been filed with the United States Securities and Exchange
Commission but is not yet effective.
The Base Shelf Prospectus, when made final and effective, will
allow Organigram to qualify the distribution of up to C$500,000,000 of common shares, preferred shares,
debt securities, subscription receipts, warrants, and units during
the 25-month period that the Base Shelf Prospectus remains
effective. The specific terms of any future offering of securities
will be established in a prospectus supplement filed with the
applicable Canadian and US regulatory authorities. The Base Shelf
Prospectus when final and effective, will provide flexibility for
financing options to pursue the Corporation's objectives.
A copy of the Base Shelf Prospectus can be found on SEDAR at
www.sedar.com and a copy of the Registration Statement can be found
on EDGAR at www.sec.gov.
No offer to buy any securities of the Corporation can be
accepted until the Registration Statement has become effective.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly-owned subsidiaries include: Organigram
Inc., a licensed producer of cannabis and cannabis-derived products
in Canada and The Edibles and
Infusions Corporation, a cannabis infused soft chew and
confectionary manufacturer in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in
Canada, as well as developing
international business partnerships to extend the Corporation's
global footprint. Organigram has also developed a portfolio of
legal adult use recreational cannabis brands including The Edison
Cannabis Company, Indi, Bag o' Buds, SHRED and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick with another leased
manufacturing facility in Winnipeg,
Manitoba. Organigram is regulated by the Cannabis Act and
the Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as "plans", "expects", "estimates",
"intends", "anticipates", "believes" or variations of such words
and phrases or state that certain actions, events, or results
"may", "could", "would", "might" or "will" be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in Organigram's most recent annual
information form, management's discussion and analysis and other
Corporation documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). In addition, there
can be no assurance that Organigram will obtain a receipt
qualifying a final short form base shelf prospectus, that any
prospectus supplements will be filed, that any financings will be
completed under the short form base shelf prospectus, and that the
objectives sought from any financings will be fulfilled. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Corporation believes that the assumptions and factors
used in preparing the forward-looking information in this news
release are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Corporation disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise. The descriptions of the
terms of the agreements referenced in this release are qualified by
the terms of the agreements themselves, copies of which shall be
filed under Organigram's profile on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov).
SOURCE OrganiGram
